Figure 2

Total methotrexate concentration and MTXPG3-5/1-2 ratio in red blood cells of rheumatoid arthritis patients with or without adverse events during methotrexate therapy.
(A) Total methotrexate concentration. (B) MTXPG3-5/1-2 ratio.
Total methotrexate concentration and MTXPG3-5/1-2 ratio in red blood cells of rheumatoid arthritis patients with or without adverse events during methotrexate therapy.
(A) Total methotrexate concentration. (B) MTXPG3-5/1-2 ratio.